Starpharma Holdings Limited (ASX:SPL)
Australia · Delayed Price · Currency is AUD 0.7200
-0.0100 (-1.37%)
May 8, 2026, 4:10 PM AEST
Starpharma Holdings Market Cap
Starpharma Holdings has a market cap or net worth of 303.23 million as of May 8, 2026. Its market cap has increased by 647.46% in one year.
Market Cap
303.23M
Enterprise Value
285.77M
Revenue
14.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.72
Market Cap Chart
Since September 28, 2000, Starpharma Holdings's market cap has increased from 50.00M to 303.23M, an increase of 506.45%. That is a compound annual growth rate of 7.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 303.23M | 101.40% |
| Dec 31, 2025 | 150.56M | 227.36% |
| Dec 31, 2024 | 45.99M | -34.30% |
| Dec 29, 2023 | 70.01M | -68.87% |
| Dec 30, 2022 | 224.87M | -58.74% |
| Dec 31, 2021 | 544.95M | -14.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Opthea | 738.77M |
| Clinuvel Pharmaceuticals | 480.07M |
| Racura Oncology | 459.45M |
| Tetratherix | 253.83M |
| Orthocell | 233.32M |
| Actinogen Medical | 168.80M |
| Recce Pharmaceuticals | 146.04M |
| Nyrada | 135.95M |